Leuprolide Completed Phase 2 Trials for Alzheimer's Disease (AD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00063310ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation
NCT00076440Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study